GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HeXun Biosciences Co Ltd (ROCO:6986) » Definitions » Current Accrued Expense

HeXun Biosciences Co (ROCO:6986) Current Accrued Expense : NT$0.0 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is HeXun Biosciences Co Current Accrued Expense?

HeXun Biosciences Co's Current Accrued Expense for the quarter that ended in Dec. 2024 was NT$0.0 Mil.


HeXun Biosciences Co Current Accrued Expense Historical Data

The historical data trend for HeXun Biosciences Co's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeXun Biosciences Co Current Accrued Expense Chart

HeXun Biosciences Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Current Accrued Expense
- - - - -

HeXun Biosciences Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Current Accrued Expense Get a 7-Day Free Trial - - - - -

HeXun Biosciences Co Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


HeXun Biosciences Co Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of HeXun Biosciences Co's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


HeXun Biosciences Co Business Description

Traded in Other Exchanges
N/A
Address
Chunri Road, 6 F., No. 1490, Taoyuan District, Taoyuan, TWN
HeXun Biosciences Co Ltd is engaged in the research and development of cell drugs and cell derivatives. It conducts research and development jointly with medical research institutions to use stem cells to treat cardiovascular, immune-inflammatory, and neurodegenerative diseases to develop innovative cell drugs and treatment methods. The company's main business items are new drug research and development, biotechnology services, and research and development services, such as: commissioned research and development and production services for cell medicine, agency testing and development services, and biomedical consulting services, etc.

HeXun Biosciences Co Headlines

No Headlines